Navigation Links
Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo'
Date:4/17/2008

SALT LAKE CITY, April 17 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced the introduction of two new products: the DynaPro Spinal Health System for treating back pain and the Dynatron X5 "Turbo" soft-tissue oscillation therapy unit.

"The new DynaPro Spinal Health System uses a four-phase treatment regimen combining the benefits of decompression with light therapy, core-stabilization exercises and nutrition," said Larry K. Beardall, executive vice president of sales and marketing. "Decompression therapy has been shown effective in relieving pain associated with a host of back problems including herniated discs, degenerative disc disease, sciatica and pinched nerves."

In addition to offering the most comprehensive approach to the effective treatment of many of the most common causes of back and neck pain, the DynaPro Spinal Health System incorporates a state-of-the-art marketing and patient- awareness program to help practitioners promote this proven, non-surgical pain relief treatment. With Dynatronics' revolutionary "Play Before You Pay" program, practitioners are able to "test drive" the concept by pre-marketing treatments prior to purchasing the system.

Another new product introduced this month is also being well received by the rehabilitation market. The new Dynatron X5 "Turbo" is three times more powerful than the original X5 device. It creates an electrostatic field within the patient that results in a highly effective treatment for acute as well as chronic pain. Soft-tissue oscillation therapy has proven to be very effective in the treatment of various orthopedic and sports injuries, and is gaining popularity in sports medicine.

"We notice immediate reductions in acute edema and joint stiffness," reported Mike Cembellin, Director of Sports Medicine, Santa Clara University. "The results from the X5 are impressive."

"We believe there is remarkable potential for both these new products," added Beardall. "The demand they will generate is expected to raise our fourth quarter results higher than previously anticipated."

Initial shipments of the new DynaPro Spinal Health System and the X5 "Turbo" have begun this month.

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, pain management, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets.

This press release contains forward-looking statements. Those statements include references to the company's expectations of future events. Actual results may vary from the views expressed in the forward-looking statements, including but not limited to references to efficacy of treatments, potential for the new products, expectations concerning operating results ahead of previous expectations. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, FDA clearance of new products, and the risk factors listed from time to time in the company's SEC reports, including, but not limited to the report on Form 10-KSB for the year ended June 30, 2007 and subsequent quarterly reports.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynatronics Introduces New Synergie Elite Aesthetic Line
2. Dynatronics Acquisitions Increase Sales 100 Percent in Second Quarter
3. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
4. Dynatronics Announces $250,000 Increase in Stock Buyback Program
5. Dynatronics Acquisitions Increase Sales 91 Percent in First Quarter
6. Dynatronics to Release First Quarter Results Monday, November 19, 2007; Conference Call Set for 1:30 p.m. ET
7. Dynatronics Adds Three Additional Direct Sales Reps
8. Dynatronics Announces Strong Fourth Quarter Profit
9. GHX Introduces NuVia(TM), an Artificial Intelligence-based Technology That Enables a New Approach to Content Management for Healthcare Providers
10. Mediware Introduces Comprehensive Vision for Blood Center Technology
11. Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... California, committed to raising awareness for Duchenne muscular dystrophy, and funding for ... CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... The doctors ... Richmond, BC, who live with dental fear and require sedation to receive dental care. ... at ease during various procedures, from hygienic cleanings to oral surgery, at their dental ...
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... 25, 2017 , ... As Spring reignites vigilance against Zika ... to Zika virus during pregnancy, as well as other prenatal exposures like cocaine, ... , The Teratology Society is an international and multidisciplinary group of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
Breaking Medicine Technology: